NCT07141069

Brief Summary

This project aims to assess the feasibility and preliminary efficacy of a supervised group-based art intervention for adults with chronic low back pain (CLBP).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
19mo left

Started Aug 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Aug 2025Dec 2027

First Submitted

Initial submission to the registry

August 6, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

August 16, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 26, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

August 26, 2025

Status Verified

August 1, 2025

Enrollment Period

1.3 years

First QC Date

August 6, 2025

Last Update Submit

August 18, 2025

Conditions

Keywords

art therapyexpressive artchronic low back painmusculoskeletal diseasesphysiotherapy practicephysical therapistsphysiotherapists

Outcome Measures

Primary Outcomes (8)

  • Recruitment rate

    The proportion of eligible participants who agree to enrol in the study.

    Baseline

  • Retention Rate

    The proportion of participants who complete the full study protocol.

    Immediately post intervention at 8-week

  • Proportion of participants adhering to intervention

    Intervention adherence will be assessed by the proportion of participants who attended at least 80% of the scheduled group sessions out of the total number randomized. Reasons for non-adherence will be explored through qualitative interviews with participants who did not meet the attendance threshold or discontinued the program prematurely.

    Weekly from week 1 through 8

  • Acceptability of the Intervention-satisfaction

    Participants will rate their satisfaction with the program on a scale from 0 (not satisfied) to 10 (very satisfied).

    Weekly from week 1 through 8

  • Acceptability of the Intervention-perceived burden

    Participants will rate the perceived burden of the intervention on a scale from 0 (not demanding) to 10 (very demanding).

    Weekly from week 1 through 8

  • Acceptability of the Intervention-willingness to continue

    Participants will rate their willingness to continue with the program on a scale from 0 (not willing to continue) to 10 (very willing to continue).

    Weekly from week 1 through 8

  • Feasibility of Data Collection Procedures

    This outcome measure will evaluate the feasibility and acceptability of the data collection methods used in the study, including completion rates for outcome assessments. Feasibility Metrics: Completion Rates for Outcome Assessments: The number of completed assessments will be divided by the total number of scheduled assessments to calculate the completion rate.

    At 3-month post intervention

  • Safety and Adverse Events

    This outcome measure will document any adverse events or safety concerns that arise during the study, including: Undesirable medical occurrences or problems that a participant experiences during or after the intervention, lasting more than 2 days and/or causing the participant to seek additional treatment. These adverse events will be categorized into: Serious Related Adverse Events Non-Serious Adverse Events Safety Metrics: Number and type of adverse events Proportion of participants who report serious related adverse events Proportion of participants who report non-serious adverse events

    Weekly from week 1 through 8

Secondary Outcomes (6)

  • Global Impression of Change scale

    Immediately (at the 8-week timepoint) and at the 3-month follow-up post-intervention

  • Numeric Pain Rating Scale (NPRS)

    Baseline, immediately post intervention (at 8th week), and 3 month follow up post intervention

  • Acceptance and Action Questionnaire II (AAQ-II)

    Baseline, immediately post intervention (at 8th week), and 3 month follow up post intervention

  • EQ-5D-5L

    Baseline, immediately post intervention (at 8th week), and 3 month follow up post intervention

  • Roland Morris Disability Index

    Baseline, immediately post intervention (at 8th week), and 3 month follow up post intervention

  • +1 more secondary outcomes

Study Arms (2)

Expressive art therapy group

EXPERIMENTAL

One hour of expressive art intervention, followed by exercise training.

Other: Art therapy combined with Exercise

Exercise group

ACTIVE COMPARATOR

The control group will participate in one hour of exercises focused on progressive back strengthening and general reconditioning, supplemented with education on back care to promote self-management of low back pain

Other: Exercise

Interventions

one hour of expressive art intervention followed by one hour of exercise training. The art therapy will be conducted in small groups of eight participants, facilitated by a part-time registered expressive art therapist. Each session begins with a 5-minute introduction and check-in, welcoming participants and inviting them to share their current status. This is followed by a 10-minute brief mindfulness exercise to help center participants and promote relaxation, setting the stage for the creative activities that follow. The core of each session consists of a 20-minute art-making process centered around specific themes that guide participants in exploring their pain and personal narratives.

Expressive art therapy group

each one-hour session in the exercise control group will involve progressive back and general reconditioning exercises, along with back care education to support self-management of LBP.

Exercise group

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • aged 18 years to 59 years old
  • currently experiencing non-specific low back pain for at least three months
  • who have sought medical treatment for CLBP
  • can read and write in Traditional Chinese

You may not qualify if:

  • lumbar spinal stenosis
  • confirmed dementia
  • severe cognitive impairment
  • serious major medical or psychiatric disorders
  • currently receiving physiotherapy, cognitive therapy, or psychological treatments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Rehabilitation Sciences, The Hong Kong Polytechnic University

Hong Kong, Hong Kong, 0000, Hong Kong

RECRUITING

The Hong Kong Polytechnic University

Hong Kong, Kowloon, Hong Kong

NOT YET RECRUITING

MeSH Terms

Conditions

Musculoskeletal Diseases

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Fadi MQ Al Zoubi, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Eligible participants will be randomized using computer-generated numbers placed in sealed, opaque envelopes, allocating them into two groups: the expressive art therapy plus exercises group or the exercise-only group on a 1:1 basis. A research assistant not involved in the study will manage allocation. Randomization will stratify participants based on sex and functional level to ensure balanced representation in both groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 6, 2025

First Posted

August 26, 2025

Study Start

August 16, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

August 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

All personal data will be anonymized. We will minimize our use of personal data in the study as much as possible. The data will be kept for 5 years after project completion, with limited access by Dr. Fadi Al Zoubi

Locations